Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Andres Cardenas, Robert Lowe, Sangik Oh, Sheila Bodkin, Tom Kenney, Wayne W. Lamorte & Nezam H. Afdhal. (2008) Hemodynamic effects of substance P and its receptor antagonist RP67580 in anesthetized rats with carbon tetrachloride-induced cirrhosis. Scandinavian Journal of Gastroenterology 43:3, pages 328-333.
Read now
Read now
Christine Winkler Dümcke & Søren Møller. (2008) Autonomic dysfunction in cirrhosis and portal hypertension. Scandinavian Journal of Clinical and Laboratory Investigation 68:6, pages 437-447.
Read now
Read now
Søren Møller, Flemming Bendtsen & Jens H. Henriksen. (2006) Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume. Scandinavian Journal of Gastroenterology 41:4, pages 451-458.
Read now
Read now
Søren Møller, Flemming Bendtsen & Jens H. Henriksen. (2005) Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome. Scandinavian Journal of Gastroenterology 40:5, pages 491-500.
Read now
Read now
J. H. Henriksen. (2004) Volume adaptation in chronic liver disease: on the static and dynamic location of water, salt, protein and red cells in cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 64:6, pages 523-534.
Read now
Read now
Articles from other publishers (35)
Fereshteh Pashayee-khamene, Behzad Hatami, Makan Cheraghpour & Zahra Yari. (2023) Keeping an eye on the nutrition: The importance of nutrition management on cardiometabolic risk factors in cirrhotic patients. Clinical Nutrition ESPEN 58, pages 186-192.
Crossref
Crossref
Maya Risteska, Ludmila Vladimirova-Kitova & Vladimir Andonov. (2022) Serum NT-ProBNP potential marker of cirrhotic cardiomyopathy. Folia Medica 64:5, pages 740-745.
Crossref
Crossref
Necati Örmeci. (2022) Endothelins and liver cirrhosis. Portal Hypertension & Cirrhosis 1:1, pages 66-72.
Crossref
Crossref
Enrico Maria Zardi, Chiara Giorgi, Aldo Dobrina, Elena Vecile & Domenico Maria Zardi. (2020) Analogies and differences between cirrhotic cardiomyopathy and hepatopulmonary syndrome. Medicinal Research Reviews 41:2, pages 739-753.
Crossref
Crossref
Laura Caracuel, Esther Sastre, María Callejo, Raquel Rodrigues-Díez, Ana B. García-Redondo, Isabel Prieto, Carlos Nieto, Mercedes Salaices, Ma Ángeles Aller, Jaime Arias & Javier Blanco-Rivero. (2020) Hepatic Encephalopathy-Associated Cerebral Vasculopathy in Acute-on-Chronic Liver Failure: Alterations on Endothelial Factor Release and Influence on Cerebrovascular Function. Frontiers in Physiology 11.
Crossref
Crossref
Satoshi Tsuchiya, Yasuharu Matsumoto, Tsuyoshi Doman, Taku Fujiya, Jun Sugisawa, Akira Suda, Koichi Sato, Shohei Ikeda, Tomohiko Shindo, Yoku Kikuchi, Kiyotaka Hao, Jun Takahashi, Waku Hatta, Tomoyuki Koike, Atsushi Masamune, Yoshikatsu Saiki, Hisanori Horiuchi & Hiroaki Shimokawa. (2020) Disappearance of Angiodysplasia Following Transcatheter Aortic Valve Implantation in a Patient with Heyde's Syndrome: A Case Report and Review of the Literature. Journal of Atherosclerosis and Thrombosis 27:3, pages 271-277.
Crossref
Crossref
María-Jimena Muciño-Bermejo. (2020) Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations. Annals of Hepatology 19:2, pages 145-152.
Crossref
Crossref
Jessica H. Huston & Anna R. Hemnes. 2020. Pulmonary Hypertension. Pulmonary Hypertension
147
171
.
Laura Caracuel, Esther Sastre, Pablo Llévenes, Isabel Prieto, Tania Funes, Mª Ángeles Aller, Jaime Arias, Gloria Balfagón & Javier Blanco-Rivero. (2019) Acute-on-chronic liver disease enhances phenylephrine-induced endothelial nitric oxide release in rat mesenteric resistance arteries through enhanced PKA, PI3K/AKT and cGMP signalling pathways. Scientific Reports 9:1.
Crossref
Crossref
Søren Møller, Signe Wiese, Hanne Halgreen & Jens D. Hove. (2016) Diastolic dysfunction in cirrhosis. Heart Failure Reviews 21:5, pages 599-610.
Crossref
Crossref
Signe Wiese, Flemming Bendtsen & Søren Møller. 2016. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease
573
599
.
M. Ferko. (2015) Content of Some Endothelium-Dependent Vasoactive Substances of Blood Plasma, Indicators of Renin-Aldosterone System, Natriuretic Hormone in Patients with Decompensated Liver Cirrhosis and their Dependence on the Severity Grade of Portal Hypertension. Lviv clinical bulletin 4:12, pages 48-55.
Crossref
Crossref
Søren Møller & Flemming Bendtsen. (2015) Cirrhotic Multiorgan Syndrome. Digestive Diseases and Sciences 60:11, pages 3209-3225.
Crossref
Crossref
Signe Wiese, Flemming Bendtsen & Søren Møller. 2015. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease
1
27
.
Søren Møller. (2014) Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World Journal of Gastroenterology 20:42, pages 15499.
Crossref
Crossref
Prabha Sawant, C. Vashishtha & M. Nasa. (2011) Management of Cardiopulmonary Complications of Cirrhosis. International Journal of Hepatology 2011, pages 1-11.
Crossref
Crossref
P. Sharma, A. Kumar, S. Jha, S. R. Mishra, B. C. Sharma & S. K. Sarin. (2010) The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Alimentary Pharmacology & Therapeutics 32:1, pages 105-112.
Crossref
Crossref
María Martell. (2010) Physiopathology of splanchnic vasodilation in portal hypertension. World Journal of Hepatology 2:6, pages 208.
Crossref
Crossref
Phillip S. Mushlin & Simon Gelman. 2010. Miller's Anesthesia. Miller's Anesthesia
411
440
.
William Kemp, Stuart Roberts & Henry Krum. (2008) Increased circulating urotensin II in cirrhosis: Potential implications in liver disease. Peptides 29:5, pages 868-872.
Crossref
Crossref
Ton Lisman, Tamara N. Bongers, Jelle Adelmeijer, Harry L.A. Janssen, Moniek P.M. de Maat, Philip G. de Groot & Frank W.G. Leebeek. (2006) Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 44:1, pages 53-61.
Crossref
Crossref
Robert E. Shangraw. (2006) Metabolic Issues in Liver Transplantation. International Anesthesiology Clinics 44:3, pages 1-20.
Crossref
Crossref
Jens H Henriksen. (2006) Liver cirrhosis and arterial hypertension. World Journal of Gastroenterology 12:5, pages 678.
Crossref
Crossref
Zi-Qing Hei. (2006) Changes of nitric oxide and endothelin, thromboxane A2 and prostaglandin in cirrhotic patients undergoing liver transplantation. World Journal of Gastroenterology 12:25, pages 4049.
Crossref
Crossref
Wim Laleman, Lien Van Landeghem, Alexander Wilmer, Johan Fevery & Frederik Nevens. (2005) Portal hypertension: from pathophysiology to clinical practice. Liver International 25:6, pages 1079-1090.
Crossref
Crossref
Ramón BatallerPau Sancho-BruPere GinêsDavid A. Brenner. (2005) Liver Fibrogenesis: A New Role for the Renin–Angiotensin System. Antioxidants & Redox Signaling 7:9-10, pages 1346-1355.
Crossref
Crossref
RHYS B VAUGHAN, JAMES A ANGUS & PETER W ANGUS. (2005) Vasoconstrictor responses are normal but prostanoid‐mediated vasodilatation is enhanced in human cirrhotic mesenteric arteries. Journal of Gastroenterology and Hepatology 20:8, pages 1158-1164.
Crossref
Crossref
Søren Møller & Jens Henriksen. 2005. Ascites and Renal Dysfunction in Liver Disease. Ascites and Renal Dysfunction in Liver Disease
137
155
.
Ana Rosa Rincón-Sánchez, Amador Covarrubias, Ana María Rivas-Estilla, José Pedraza-Chaverrí, Cristino Cruz, María Cristina Islas-Carbajal, Arturo Panduro, Alma Estanes & Juan Armendáriz-Borunda. (2005) PGE2 alleviates kidney and liver damage, decreases plasma renin activity and acute phase response in cirrhotic rats with acute liver damage. Experimental and Toxicologic Pathology 56:4-5, pages 291-303.
Crossref
Crossref
Andrés Cárdenas & Pere Ginès. 2005. Portal Hypertension. Portal Hypertension
65
84
.
Jens H. Henriksen & Søren Møller. (2004) Hypertension and liver disease. Current Hypertension Reports 6:6, pages 453-461.
Crossref
Crossref
S. Møller & J. H. Henriksen. (2004) Pathogenesis and pathophysiology of hepatorenal syndrome – is there scope for prevention?. Alimentary Pharmacology & Therapeutics 20:s3, pages 31-41.
Crossref
Crossref
Florence Wong. 2004. Atlas of the Liver. Atlas of the Liver
219
254
.
Andrés Cárdenas & Vicente Arroyo. (2003) Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. Best Practice & Research Clinical Endocrinology & Metabolism 17:4, pages 607-622.
Crossref
Crossref
Andrés Cárdenas & Vicente Arroyo. (2003) Hepatorenal syndrome. Annals of Hepatology 2:1, pages 23-29.
Crossref
Crossref